Purisys, LLC has appointed Christopher Speed, MND, as vice president for its food, beverage and nutrition consumer products business. Speed has spent over two decades in the nutraceutical and food space, bringing a background in nutrition science and consumer finished product development, along with experience at some of the leading food and nutraceutical companies in the world. He will be responsible for developing Purisys’ cannabinoid offerings, most notably cannabidiol (CBD), for nutritive and bioactive applications across a spectrum of consumer product types. He will be based in Purisys’ Athens, GA, office.
 
According to Jim Mish, CEO of Purisys, the appointment of Speed is in line with the company’s mission to become a trusted innovation and development partner for consumer products companies. “After combining a background in nutritional biochemistry with global sales and marketing leadership, Chris Speed brings a deep and relevant background to how we will best deliver accountable solutions to the food, beverage, and nutraceuticals industry. His experience and strengths are perfect to help us market and steer our synthetic ‘nature-identical’ CBD—the first to be de-scheduled by the DEA—through this incredibly competitive landscape and to the ultimate success of the food, beverage and nutraceutical industry that we serve,” he said.
 
On Jan. 1, Purisys, LLC was spun off from a pharmaceutical API company. The company now focuses exclusively as an ingredient and solutions provider to pharmaceutical and consumer products companies looking to use CBD and other cannabinoid-based ingredients. In nutritive applications, including food, beverage and nutraceuticals, Purisys’ portfolio of over 50 cannabinoids means an entire new range of bioactives that can contribute to unique, efficacious consumer products. For these products, Purisys said it has been and will continue to invest in applications development capabilities, including facilities and personnel.
 
According to Speed, Purisys’ ability to deliver its broad portfolio of ultra-pure cannabinoid bioactives is an important asset for the industries with which he will interact. “The most discerning and trusted customer demands excellence in quality, purity and safety and will not tolerate confusion that is driven by slick marketing fiction, in lieu of the facts.” Speed said. “Purisys is adamantly aware of this and is well poised to help its customers achieve immediate and long-lasting product acceptance through its category-altering cannabinoid bioactive solutions.
 
Prior to his experience at NattoPharma, Speed was a global sales manager and vice president of sales for Wiley’s Finest Wild Alaskan Fish Oil.